Moody's affirms Yestar's Ba3 ratings; revises outlook to negative
For the full text of this story please click the following link: http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_406497&WT.mc_id=AM~UmV1dGVyc05ld3NfQU1QU19TQl9OUl9DVl9SYXRpbmdfTmV3c19BbGw=~20190821_PR_406497
Recent news on Yestar Healthcare Holdings
See all newsBrief: Yestar Healthcare Says Guangzhou Shengshiyuan Trading Shareholders Passed Resolution To Dissolve
Brief: Yestar Healthcare Expects FY2025 Net Loss Of Not Less Than RMB65 Million
Brief: Yestar Healthcare Says Exploring And Proposes To Invest In Advanced Materials Industry
Brief: Yestar Healthcare Considering JV With Genetron Health In Singapore, Indonesia & Malaysia
Brief: Yestar Healthcare Says Wang Chunlai Appointed As Executive Director